An update on factor XI structure and function-Reference-Cited by-同舟云学术

An update on factor XI structure and function

Published:2018-01 Issue: Volume:161 Page:94-105
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Mohammed Bassem M.,Matafonov Anton,Ivanov Ivan,Sun Mao-fu,Cheng Qiufang,Dickeson S. Kent,Li Chan,Sun David,Verhamme Ingrid M.,Emsley Jonas,Gailani David

Funder

National Institutes of Health

British Heart Foundation

Publisher

Elsevier BV

Subject

Hematology

Reference142 articles.

1. Structure and function of factor XI;Emsley;Blood,2010

2. Molecular basis of blood coagulation;Brummel-Ziedens,2013

3. Association of factor XI and high molecular weight kininogen in human plasma;Thompson;J. Clin. Invest.,1977

4. Studies of binding of prekallikrein and factor XI to high molecular weight kininogen and its light chain;Thompson;Proc. Natl. Acad. Sci. U. S. A.,1979

5. Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor;Kaplan;Ann. N. Y. Acad. Sci.,1981

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protonated-chitosan sponge with procoagulation activity for hemostasis in coagulopathy;Bioactive Materials;2024-11

2. Milvexian, a novel factor XIa inhibitor for stroke prevention: pharmacokinetic and pharmacodynamic evaluation;Expert Opinion on Drug Metabolism & Toxicology;2024-09-02

3. The first-in-human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the factor XI monoclonal antibody SHR-2004 in healthy subjects;Expert Opinion on Investigational Drugs;2024-08-22

4. Therapeutic Potential of FXI Inhibitors: Hype or Hope?;Drugs;2024-07-29

5. Milvexian: evaluating the factor XIa inhibitor for the treatment of acute coronary syndrome;Expert Opinion on Pharmacotherapy;2024-07-02